<DOC>
	<DOCNO>NCT02251925</DOCNO>
	<brief_summary>This study prospective randomize control trial compare pregnancy outcomes frozen embryo transfer natural hormonal replacement cycle . The study population consist infertile woman regular menstrual cycle undergo IVF/ICSI frozen embryo transfer Reproductive Biomedicine Research Center , Royan institute , Tehran Iran .</brief_summary>
	<brief_title>Frozen Embryo Transfer Natural Hormonal Replacement Cycles</brief_title>
	<detailed_description>In study patient undergo frozen embryo transfer randomly allocate prepared transfer use either natural cycle ( without hCG ovulation induction ) Hormonal cycle ( without administration GnRH-a ) In natural cycle without hCG , daily monitoring urinary LH start day eight cycle frozen-thawed embryo transfer plan 3-5 day detection LH surge , observe mature follicle ultrasound endometrial thickness 7mm cleavage embryo . In natural cycle hCG , detection mature follicles ultrasound endometrial thickness 7mm , 10,000IU hCG inject ovulation embryo transfer perform 3-5 day later cleavage stage . In group 3 , injection GnRH agonist ( Superfact ) subcutaneous daily dose 0.5 mg start day 17-19 natural menstrual cycle . Once pituitary desensitization confirm , hormonal treatment commence 4mg/day oral Estradiol valerate 7 day endometrial thickness adequate , Estradiol administration continue dose 100mg Progesterone administer embryo transfer , otherwise patient candidate high dosage Estradiol till favourable endometrial thickness achieve . In hormonal group without GnRH-a , endometrial preparation start daily administration 6 mg Estradiol valerate 2nd day natural menstrual cycle 6 day . Then treatment continue similar 3rd group .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<criteria>1 . Patients regular mensturation cycle 2 . Age 2037 year 3 . Patients underwent long protocol 4 . Body mass index ( BMI ) â‰¤ 30 kg/m2 5 . Patients undergo frozen embryo transfer first time 1 . Oocyte embryo donation cycle 2 . Uterine diseases malformation 3 . Hyper prolactinemia 4 . Thyroid disorder 5 . Tuberculosis 6 . Recurrent abortion history 7 . Severe endometriosis 8 . Ovulation disorder</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>37 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>infertility froze emberyo transfer hormone replacement</keyword>
</DOC>